ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer
New Standard for 2nd Line Therapy in Metastatic Gastric Cancer: VEGFR2 Ramucirumab +/- Chemotherapy
Comments 0
Login to view comments.
Click here to Login